Cargando...

Quantitative proteomic profiling of cerebrospinal fluid to identify candidate biomarkers for Alzheimer’s disease

PURPOSE: Development of novel biomarkers for AD is important for early diagnosis, monitoring disease progression and therapeutic response. The aim of this study was to identify the potential CSF biomarkers for Alzheimer's disease (AD) and evaluate these markers on independent CSF samples using...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Proteomics Clin Appl
Autores principales: Sathe, Gajanan, Na, Chan Hyun, Renuse, Santosh, Madugundu, Anil K., Albert, Marilyn, Moghekar, Abhay, Pandey, Akhilesh
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6639119/
https://ncbi.nlm.nih.gov/pubmed/30578620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prca.201800105
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!